The declining number of deaths from colorectal cancer can be attributed to increased colonoscopy screenings, but the racial disparity in South Carolina remains high, writes Dr. March Seabrook, an ACG governor from South Carolina. Continued research and outreach is needed to educate patients about the need for regular screening to help prevent the disease, he says.
Two South Carolina physicians from Consultants in Gastroenterology/South Carolina Endoscopy Center recently offered free colonoscopies to the uninsured, made possible through grants and donations. Dr. March Seabrook said he hopes to integrate the free screenings into his regular schedule and refine the program to be a model of community partnership that other doctors can adopt.
Six-week data from a 26-week Phase IIIb study of Cimzia show the drug was effective in treating Crohn's disease patients intolerant or unresponsive to infliximab. The company is seeking FDA approval for the drug.
A new study in the American Journal of Gastroenterology found many patients who had antireflux surgery saw long-term improvement or resolution of GERD symptoms. Those most likely to see long-term benefits were younger males who initially did not have difficulty swallowing.
Forest Laboratories says midstage studies on linaclotide were successful and the drug will move to Phase III studies for chronic constipation and IBS. The once-daily drug showed improvements in weekly spontaneous bowel movement at most tested doses.